Gapping down
In reaction to disappointing earnings/guidance: SYUT -6.2%
Select financial related names showing weakness: LYG -2.6%, DB -2.1%, CS -1.9%, BCS -1.7%, SAN -1.6%, HSBC -1%,BAC -0.8%
Other news: MRNS -57.9% (announces ganaxolone did not meet the primary endpoint of demonstrating a statistically significant difference from placebo), BIOS -12% (commences common stock offering), SPHS -8.6% (modestly pulling back after Friday's gains), GWPH -2% (still checking), DANG -1.8% (Shanghai -3.5% overnight), BABA -1.1% (Shanghai -3.5% overnight), TRN -0.5% (enters into an Administrative Settlement and Compliance Agreement with the Federal Highway Administration pertaining to highway products)
Analyst comments: EMES -7.7% (downgraded to Underperform at DA Davidson), OSUR -4.2% (downgraded to Mkt Perform from Outperform at Raymond James), VOD -2.1% (downgraded to Neutral from Outperform at Macquarie), SAP -1.8% (downgraded to Underperform from Hold at Jefferies), BIDU -1.7% (downgraded to Neutral from Buy at Citigroup)
In reaction to disappointing earnings/guidance: SYUT -6.2%
Select financial related names showing weakness: LYG -2.6%, DB -2.1%, CS -1.9%, BCS -1.7%, SAN -1.6%, HSBC -1%,BAC -0.8%
Other news: MRNS -57.9% (announces ganaxolone did not meet the primary endpoint of demonstrating a statistically significant difference from placebo), BIOS -12% (commences common stock offering), SPHS -8.6% (modestly pulling back after Friday's gains), GWPH -2% (still checking), DANG -1.8% (Shanghai -3.5% overnight), BABA -1.1% (Shanghai -3.5% overnight), TRN -0.5% (enters into an Administrative Settlement and Compliance Agreement with the Federal Highway Administration pertaining to highway products)
Analyst comments: EMES -7.7% (downgraded to Underperform at DA Davidson), OSUR -4.2% (downgraded to Mkt Perform from Outperform at Raymond James), VOD -2.1% (downgraded to Neutral from Outperform at Macquarie), SAP -1.8% (downgraded to Underperform from Hold at Jefferies), BIDU -1.7% (downgraded to Neutral from Buy at Citigroup)